QUANTITATIVE ESTROGEN AND PROGESTERONE-RECEPTOR LEVELS RELATED TO PROGRESSION-FREE INTERVAL IN ADVANCED BREAST-CANCER PATIENTS TREATED WITH MEGESTROL-ACETATE OR TAMOXIFEN

被引：0
|
作者：
BONOMI, P
GALE, M
VONROENN, J
ANDERSON, K
JOHNSON, P
WOLTER, J
ECONOMOU, S
机构：
[1] RUSH MED COLL,RUSH MED CTR,ROOM 830,1725 W HARRISON,CHICAGO,IL 60612
[2] CARLE CLIN,CHAMPAIGN,IL
[3] NORTHWESTERN UNIV,CHICAGO,IL 60611
来源：
SEMINARS IN ONCOLOGY | 1988年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：26 / 33
页数：8
相关论文
共 50 条
  • [31] RANDOMIZED CLINICAL-TRIAL OF MEGESTROL-ACETATE VERSUS TAMOXIFEN IN PARA-MENOPAUSAL OR CASTRATED WOMEN WITH ADVANCED BREAST-CANCER
    INGLE, JN
    AHMANN, DL
    GREEN, SJ
    EDMONSON, JH
    CREAGAN, ET
    HAHN, RG
    RUBIN, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (02): : 155 - 160
  • [32] A RANDOMIZED CROSSOVER TRIAL COMPARING MEGESTROL-ACETATE WITH TAMOXIFEN AS INITIAL HORMONE-THERAPY FOR ADVANCED BREAST-CANCER IN POSTMENOPAUSAL WOMEN
    DANIEL, F
    TYRELL, CJ
    KEEN, CW
    SPOONER, D
    TAYLOR, AR
    TARRANT, J
    BLACKLEDGE, GRP
    STUART, NSA
    WEBSTER, DJT
    REES, FLG
    CLINICAL RADIOLOGY, 1988, 39 (06) : 686 - 686
  • [33] A RANDOMIZED CROSSOVER TRIAL OF MEGESTROL-ACETATE VS TAMOXIFEN AS INITIAL TREATMENT FOR POST-MENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER
    STUART, N
    TYRELL, C
    SPOONER, D
    KEEN, C
    TAYLOR, A
    TARRANT, J
    BLACKLEDGE, G
    WEBSTER, D
    REES, G
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 859 - 860
  • [34] PROGNOSTIC-SIGNIFICANCE OF PROGESTERONE-RECEPTOR LEVELS IN ESTROGEN RECEPTOR-POSITIVE PATIENTS WITH METASTATIC BREAST-CANCER TREATED WITH TAMOXIFEN - RESULTS OF A PROSPECTIVE SOUTHWEST-ONCOLOGY-GROUP STUDY
    RAVDIN, PM
    GREEN, S
    DORR, TM
    MCGUIRE, WL
    FABIAN, C
    PUGH, RP
    CARTER, RD
    RIVKIN, SE
    BORST, JR
    BELT, RJ
    METCH, B
    OSBORNE, CK
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (08) : 1284 - 1291
  • [35] QUANTITATIVE ESTROGEN AND PROGESTERONE-RECEPTOR VALUES IN PRIMARY BREAST-CANCER AND PREDICTABILITY OF RESPONSE TO ENDOCRINE THERAPY
    FERNANDEZ, MD
    ALAGHBANDZADEH, J
    BURN, JI
    CLINICAL ONCOLOGY, 1983, 9 (03): : 245 - 250
  • [36] CONCORDANCE AND DISCORDANCE OF ESTROGEN AND PROGESTERONE-RECEPTOR CONTENT IN SEQUENTIAL BIOPSIES OF PATIENTS WITH ADVANCED BREAST-CANCER - RELATION TO SURVIVAL
    RAEMAEKERS, JM
    BEEX, LV
    KOENDERS, AJ
    PIETERS, GF
    SMALS, AG
    BENRAAD, TJ
    KLOPPENBORG, PW
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (08): : 1011 - 1018
  • [37] COMPARISON OF FLOW-CYTOMETRY AND ESTROGEN AND PROGESTERONE-RECEPTOR STATUS IN PATIENTS WITH BREAST-CANCER
    MUSS, H
    KUTE, T
    MOORE, B
    LINVILLE, C
    LONG, R
    CASE, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 184 - 184
  • [38] Outcome in patients with advanced breast cancer treated with anastrozole following loss of response to tamoxifen and megestrol acetate
    Mihaimeed, F
    Kelleher, SM
    Parbhoo, S
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S22 - S22
  • [39] THE EFFECT OF TAMOXIFEN (T) ON PROGESTERONE-RECEPTOR (PR) - RELATIONSHIP OF A RISE IN PR TO RESPONSE AND THE EFFECT OF ALTERNATING T AND MEDROXYPROGESTERONE ACETATE (MPA) IN PATIENTS WITH ADVANCED BREAST-CANCER
    BARNES, DM
    HOWELL, A
    HARLAND, RNL
    BAILDAM, AD
    SWINDELL, R
    SELLWOOD, RA
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (06): : 740 - 740
  • [40] CHANGES IN ESTROGEN-RECEPTOR, PROGESTERONE-RECEPTOR, AND PS2 EXPRESSION IN TAMOXIFEN-RESISTANT HUMAN BREAST-CANCER
    JOHNSTON, SRD
    SACCANIJOTTI, G
    SMITH, IE
    SALTER, J
    NEWBY, J
    COPPEN, M
    EBBS, SR
    DOWSETT, M
    CANCER RESEARCH, 1995, 55 (15) : 3331 - 3338
12345